# Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer

> clinical trial · VERIFIED · 2026-07-06

Status: NOT_YET_RECRUITING · Sponsor: National Cancer Institute (NCI) · Condition: Head and Neck Cancer

- Company: National Cancer Institute (NCI)
- Sector: Head and Neck Cancer
- Primary source: https://clinicaltrials.gov/study/NCT07667400

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.